Stock screenerAll disclosures →
EDGAR →
VOR
Conviction 92HealthcareScan · Mon, Aug 10, 2026VOR$23.36-1.33%
ResistanceSupportVol 14Insider sellVol MA14 1.02M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price23.36
Change-1.33%
Gap-1.86%
Rel volume4.12×
Avg volume988.65K
Avg $ vol20.47M
SMA 2020.29
SMA 5017.69
SMA 20015.32
Price vs 50+32.04%
Price vs 200+52.42%
MA stackbullish
50/200 cross—
Supertrendup · 19.07
RSI (14)69
MACD hist0.27
MACD crossbull · 7d
Stoch %K / %D84 / 91
ADX (14)36
+DI / −DI27 / 9
RSI divergence—
MACD divergence—
ATR %+6.19%
ADR %7.07%
52w high48.72
52w low1.52
From 52w high-52.06%
Above 52w low+1436.51%
New 52w highNo
SqueezeOff
Bollinger width39.17%
%B0.89
Donchian pos87.16%
Donchian high24.34
Donchian low16.67
AVWAP (52w high)15.14
vs AVWAP high+54.31%
AVWAP (52w low)15.10
vs AVWAP low+54.72%
OBV trendFlat
Chaikin MF (20)0.07
Today vs 20d4.12×
Avg vol (14d)1.02M
Avg vol (20d)988.65K
Avg $ vol (20d)20.47M
Market cap1.27B
RS 3m (vs SPY)+41.50%
RS 6m (vs SPY)+81.99%
RS line new highNo
Trend template6/8
Technical rank94.3
1 week+9.08%
1 month+22.02%
3 months+37.87%
6 months+77.47%
1 year+1028.26%
YTD+100.64%
P/E-1.82
P/B-8.41
P/S—
P/FCF-8.81
EPS-70.50
Div yield—
ROE462.68%
ROA-137.34%
Debt/Eq—
Current31.15
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-495.29%
Price target26.33
Target upside12.74%
Analyst ratingBuy
Institutional85.30%
Ent. value1.1B
Revenue—
Net income-219.59M
Gross profit—
Free cash flow-143.65M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out54.19M
Employees76
ListedFri, Feb 5, 2021
Free float29.19M
Float %70.3%
Short interest7.29M
Days to cover4.4d
Short volume67.0%
Squeeze score95 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.73 vs −$0.75
Last surprise+2.7% beat
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank94.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance21.59
Support15.45
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VOR
No recent disclosed trades by Congress in VOR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VOR · 1 buy · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ZACCARDELLI DAVID Director · Stock Option (Right to Buy) · 2026-07-07 | Grant | 42.66K | — | 2026-07-07 | 2026-07-09 |
RA Capital Healthcare Fund LP Director · Common Stock · 2026-04-22 | Sell | 165.15K | $2.6M | 2026-04-22 | 2026-04-24 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-04-22 | Sell | 165.15K | $2.6M | 2026-04-22 | 2026-04-24 |
Shah Rajeev M. Director · Common Stock · 2026-04-22 | Sell | 165.15K | $2.6M | 2026-04-22 | 2026-04-24 |
Kolchinsky Peter Director · Common Stock · 2026-04-22 | Sell | 165.15K | $2.6M | 2026-04-22 | 2026-04-24 |
Shah Rajeev M. Director · Common Stock · 2026-04-20 | Sell | 171.96K | $2.7M | 2026-04-20 | 2026-04-21 |
Kolchinsky Peter Director · Common Stock · 2026-04-20 | Sell | 171.96K | $2.7M | 2026-04-20 | 2026-04-21 |
RA Capital Healthcare Fund LP Director · Common Stock · 2026-04-20 | Sell | 171.96K | $2.7M | 2026-04-20 | 2026-04-21 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-04-20 | Sell | 171.96K | $2.7M | 2026-04-20 | 2026-04-21 |
Kolchinsky Peter Director · Common Stock · 2026-04-17 | Sell | 458.41K | $7.5M | 2026-04-17 | 2026-04-21 |
SEC filings
EDGAR filings in VOR · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.